Chen B (2019), China |
Not reported |
Vogtmann E (2020), USA |
1. Saliva sample collected after cancer diagnosis |
|
2. Unhealthy controls (benign diseases) |
|
3. Low power study for rate-specific analysis |
|
4. Information on oro-dental health was not obtained |
Half E (2019), Israel |
1. Small sample |
Serra N (2018), Canada |
Not reported |
Olson SH (2017), USA |
1. Small sample |
|
2. One-time collection of oral samples |
Di Carlo P (2019), Italy |
1. Study at a single center |
Mei Q-X (2018), China |
1. Small sample |
|
2. Analysis of bacteria only |
Erick R (2019), USA |
Not reported |
Torres PJ (2015), USA |
1. Low power study for rate-specific analysis of Streptococcus
|
|
2. Presence of tumor beyond the primary site (pancreas) |
Ren Z (2017), China |
1. Stool sample collected after cancer diagnosis |
Fan X (2018), USA |
1. One-time collection of oral samples |
|
2. Information on oro-dental health was not obtained |
|
3. Unrepresentative groups of the general population, low generalization power |
Kohi S (2021), USA |
1. Study at a single center |
|
2. Presence of confounding factors in cases and controls |
|
3. Duodenal fluid sample collected after cancer diagnosis |
Saab M (2021), France |
1 Unhealthy control (benign diseases) and no literature for comparison |
|
2. No comparison with tumor microbiota |
|
3. Possibility of contamination of samples with duodenal bacteria |
Sun H (2020), China |
Not reported |
Wei AL (2020), China |
1. Non-inclusion of other pancreatic diseases |
|
2. Only 16S rRNA sequencing for analysis |
|
3. Information on oro-dental health was not obtained |